Skip to Content
Merck
  • Binding of respiratory syncytial virus particles to platelets does not result in their degranulation in vitro.

Binding of respiratory syncytial virus particles to platelets does not result in their degranulation in vitro.

Access microbiology (2023-08-21)
Anke J Lakerveld, Elisabeth A van Erp, Puck B van Kasteren
ABSTRACT

Respiratory syncytial virus (RSV) is a major cause of severe respiratory infection in infants and the elderly. The mechanisms behind severe RSV disease are incompletely understood, but a dysregulated immune response probably plays an important role. Platelets are increasingly being recognized as immune cells and are involved in the pathology of several viruses. The release of chemokines from platelets upon activation may attract, for example, neutrophils to the site of infection, which is a hallmark of RSV pathology. In addition, since RSV infections are sometimes associated with cardiovascular events and platelets express several known RSV receptors, we investigated the effect of RSV exposure on platelet degranulation. Washed human platelets were incubated with sucrose-purified RSV particles. P-selectin and CD63 surface expression and CCL5 secretion were measured to assess platelet degranulation. We found that platelets bind and internalize RSV particles, but this does not result in degranulation. Our results suggest that platelets do not play a direct role in RSV pathology by releasing chemokines to attract inflammatory cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-RSV Antibody, glycoprotein, all type A, B strains, clone 131-2G, clone 131-2G, Chemicon®, from mouse